A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart ...
Therapy pioneered by biotechnology Chinese firm HuidaGene showed promise in animals but caused a fatal reaction in a child.
Everyday Health on MSN
4 signs your Duchenne muscular dystrophy treatment is working
It can be difficult to tell if medication is helping slow the progression of Duchenne muscular dystrophy. Get expert advice ...
A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart ...
Cumberland Pharmaceuticals Inc. is an innovation-focused biopharmaceutical company developing new therapies to address ...
DALLAS, August 11, 2026--(BUSINESS WIRE)--Signature Biologics, a clinical-stage cell therapy company committed to rigorous clinical research and to the DMD community, today announced that the U.S.
Duchenne muscular dystrophy (DMD) is an X-linked genetic disease that causes the muscles—including the heart—to gradually weaken and waste away. Affecting almost exclusively boys and young men, most ...
Duchenne muscular dystrophy (DMD) is a neuromuscular disorder that results from mutations in the DMD gene. Gene therapies for DMD change genetic material in a person’s body to treat this condition.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results